VTGN icon

VistaGen Therapeutics

116 hedge funds and large institutions have $168M invested in VistaGen Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

19% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 37

38% less capital invested

Capital invested by funds: $269M → $168M (-$101M)

92% less call options, than puts

Call options by funds: $41K | Put options by funds: $487K

Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$41K
Puts
$487K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$633K
27
$606K
28
$508K
29
$479K
30
$455K
31
$392K
32
$356K
33
$339K
34
$314K
35
$307K
36
$263K
37
$250K
38
$239K
39
$217K
40
$200K
41
$192K
42
$165K
43
$158K
44
$156K
45
$148K
46
$145K
47
$140K
48
$138K
49
$119K
50
$117K